Tunisia
· Delayed Price · Currency is TND BVMT: SIPHA Statistics
Total Valuation
Société des Industries Pharmaceutiques de Tunisie - has a market cap or net worth of TND 7.92 million.
| Market Cap | 7.92M |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Société des Industries Pharmaceutiques de Tunisie - has 1.80 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 1.80M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.39 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.51
| Current Ratio | 0.51 |
| Quick Ratio | 0.16 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.69 |
| Interest Coverage | -7.09 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -26.40% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 27,186 |
| Profits Per Employee | -22,990 |
| Employee Count | 744 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 0.76 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.22% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -0.22% |
| 50-Day Moving Average | 5.11 |
| 200-Day Moving Average | 4.73 |
| Relative Strength Index (RSI) | 20.88 |
| Average Volume (20 Days) | 112 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Société des Industries Pharmaceutiques de Tunisie - had revenue of TND 20.23 million and -17.10 million in losses. Loss per share was -9.50.
| Revenue | 20.23M |
| Gross Profit | 9.19M |
| Operating Income | -13.92M |
| Pretax Income | -17.06M |
| Net Income | -17.10M |
| EBITDA | -12.53M |
| EBIT | -13.92M |
| Loss Per Share | -9.50 |
Balance Sheet
The company has 95,207 in cash and 26.01 million in debt, giving a net cash position of -25.92 million or -14.40 per share.
| Cash & Cash Equivalents | 95,207 |
| Total Debt | 26.01M |
| Net Cash | -25.92M |
| Net Cash Per Share | -14.40 |
| Equity (Book Value) | -31.21M |
| Book Value Per Share | -17.34 |
| Working Capital | -23.23M |
Cash Flow
In the last 12 months, operating cash flow was -14.92 million and capital expenditures -453,460, giving a free cash flow of -15.37 million.
| Operating Cash Flow | -14.92M |
| Capital Expenditures | -453,460 |
| Free Cash Flow | -15.37M |
| FCF Per Share | -8.54 |
Margins
Gross margin is 45.45%, with operating and profit margins of -68.83% and -84.57%.
| Gross Margin | 45.45% |
| Operating Margin | -68.83% |
| Pretax Margin | -84.34% |
| Profit Margin | -84.57% |
| EBITDA Margin | -61.96% |
| EBIT Margin | -68.83% |
| FCF Margin | n/a |
Dividends & Yields
Société des Industries Pharmaceutiques de Tunisie - does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -215.96% |
| FCF Yield | -194.06% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Société des Industries Pharmaceutiques de Tunisie - has an Altman Z-Score of -3.9. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.9 |
| Piotroski F-Score | n/a |